Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation
Milad Ashrafizadeh, Wei Zhang, Yu Tian, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 1, pp. 229-260
Closed Access | Times Cited: 15

Showing 15 citing articles:

Peptide-functionalized, -assembled and -loaded nanoparticles in cancer therapy
Jingyuan Dai, Milad Ashrafizadeh, Amir R. Aref, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 103981-103981
Closed Access | Times Cited: 65
Micelle-engineered nanoplatforms for precision oncology
Wei Gao, Ashkan Bigham, Matineh Ghomi, et al.
Chemical Engineering Journal (2024) Vol. 495, pp. 153438-153438
Closed Access | Times Cited: 12
Role of long non-coding RNAs and natural products in prostate cancer: insights into key signaling pathways
Ahmed S. Doghish, Sherif S. Abdel Mageed, Mohamed Bakr Zaki, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access | Times Cited: 1
Natural products and long non-coding RNAs in prostate cancer: insights into etiology and treatment resistance
Hanan Elimam, Mohamed Bakr Zaki, Mai A. Abd‐Elmawla, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access | Times Cited: 1
Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis
Yu Tian, Meng Zhang, Lixia Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Exosomal miR-4516 derived from ovarian cancer stem cells enhanced cisplatin tolerance in ovarian cancer by inhibiting GAS7
Xin Pan, Xiu Shi, Hong Zhang, et al.
Gene (2024) Vol. 927, pp. 148738-148738
Closed Access | Times Cited: 5
Multifunctional and stimuli-responsive liposomes in hepatocellular carcinoma diagnosis and therapy
Seyedeh Setareh Samaei, Mahshid Daryab, Sarah Gholami, et al.
Translational Oncology (2024) Vol. 45, pp. 101975-101975
Open Access | Times Cited: 4
Multi-Drug Resistance and Breast Cancer Progression via Toll-Like Receptors (TLRs) Signaling
Harikumar Pallathadka, Abdulrahman Qais Khaleel, Ahmed Hussein Zwamel, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 4, pp. 3015-3030
Closed Access | Times Cited: 4
Small extracellular vesicles: crucial mediators for prostate cancer
Sijie Tang, Huiying Cheng, Xueyan Zang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Phase 1 study of HP518, a PROTAC AR degrader in patients with mCRPC: results on safety, pharmacokinetics, and anti-tumor activity
Arun Azad, Howard Gurney, Craig Underhill, et al.
Investigational New Drugs (2025)
Closed Access
Deciphering the role of circular RNAs in cancer progression under hypoxic conditions
Hamza Abu Owida, Raed Obaid Saleh, Suleiman Ibrahim Shelash Mohammad, et al.
Medical Oncology (2025) Vol. 42, Iss. 6
Closed Access
miRNAs dysregulation in ankylosing spondylitis: A review of implications for disease mechanisms, and diagnostic markers
Osama A. Mohammed, Mushabab Alghamdi, Masoud I.E. Adam, et al.
International Journal of Biological Macromolecules (2024) Vol. 268, pp. 131814-131814
Closed Access | Times Cited: 1
Implications of c-Myc in the pathogenesis and treatment efficacy of urological cancers
Kiavash Hushmandi, Seyed Hassan Saadat, Mehdi Raei, et al.
Pathology - Research and Practice (2024) Vol. 259, pp. 155381-155381
Closed Access | Times Cited: 1
Heme Oxygenase-1 and Prostate Cancer: Function, Regulation, and Implication in Cancer Therapy
Ramia J. Salloom, Iman M. Ahmad, Dania Z. Sahtout, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9195-9195
Open Access | Times Cited: 1
Chiral inorganic nanomaterials in the tumor microenvironment: A new chapter in cancer therapy
Xueyi Song, Chenjing Hao, Yao Li, et al.
Pharmacological Research (2024) Vol. 208, pp. 107386-107386
Open Access
Highlighting function of Wnt signalling in urological cancers: Molecular interactions, therapeutic strategies, and (nano)strategies
Mehrdad Hashemi, Mahdi Rezaei, Hadi Rezaeiaghdam, et al.
Translational Oncology (2024) Vol. 50, pp. 102145-102145
Open Access
Dronedarone hydrochloride inhibits gastric cancer proliferation in vitro and in vivo by targeting SRC
Xuebo Lu, Weizhe Zhang, Xiaoxiao Yang, et al.
Translational Oncology (2024) Vol. 50, pp. 102136-102136
Closed Access
Page 1

Scroll to top